Total Payments
$9,893
2024 Payments
$1,963
Companies
37
Transactions
525
Medicare Patients
1,677
Medicare Billing
$225,480
Payment Breakdown by Category
Food & Beverage$9,780 (98.9%)
Education$113.50 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,780 | 520 | 98.9% |
| Education | $113.50 | 5 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,160 | 62 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,041 | 45 | $0 (2024) |
| Gilead Sciences, Inc. | $993.00 | 39 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $936.50 | 37 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $666.54 | 32 | $0 (2024) |
| PFIZER INC. | $642.28 | 42 | $0 (2024) |
| Allergan, Inc. | $473.81 | 39 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $460.17 | 29 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $391.06 | 22 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $370.95 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,963 | 82 | Boehringer Ingelheim Pharmaceuticals, Inc. ($407.21) |
| 2023 | $2,019 | 99 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($238.86) |
| 2022 | $1,989 | 101 | Gilead Sciences, Inc. ($346.87) |
| 2021 | $1,698 | 101 | Gilead Sciences, Inc. ($259.58) |
| 2020 | $877.84 | 58 | Allergan, Inc. ($152.73) |
| 2019 | $662.74 | 40 | Allergan Inc. ($110.06) |
| 2018 | $333.28 | 23 | Allergan Inc. ($136.06) |
| 2017 | $349.29 | 21 | Galderma Laboratories, L.P. ($113.50) |
All Payment Transactions
525 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: DIABETES | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $33.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Gastroenterology | ||||||
| 12/13/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.54 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $30.26 | General |
| 12/04/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.25 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $28.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: DIABETES | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: DIABETES | ||||||
| 11/08/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: ANTIBIOTIC | ||||||
| 11/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $33.16 | General |
| 10/30/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $28.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: DIABETES | ||||||
| 10/21/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $32.95 | General |
| 10/02/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Gastroenterology | ||||||
| 09/25/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $18.99 | General |
| Category: Cardiology | ||||||
| 09/23/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: DIABETES | ||||||
| 09/11/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/27/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $30.98 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/14/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.34 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 389 | 674 | $181,836 | $51,151 |
| 2022 | 5 | 317 | 653 | $147,150 | $47,891 |
| 2021 | 5 | 493 | 930 | $197,553 | $66,710 |
| 2020 | 6 | 478 | 773 | $166,351 | $59,728 |
Total Patients
1,677
Total Services
3,030
Medicare Billing
$225,480
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 100 | 207 | $58,581 | $18,422 | 31.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 131 | 306 | $61,200 | $17,673 | 28.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 128 | 131 | $45,195 | $11,231 | 24.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 30 | $16,860 | $3,824 | 22.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 109 | 296 | $71,125 | $23,094 | 32.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 89 | 235 | $39,827 | $12,933 | 32.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 66 | 68 | $17,198 | $5,478 | 31.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 34 | 34 | $15,606 | $5,272 | 33.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 19 | 20 | $3,394 | $1,114 | 32.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 167 | 461 | $76,065 | $26,033 | 34.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 158 | 300 | $70,800 | $23,951 | 33.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 100 | 101 | $24,644 | $8,337 | 33.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 51 | 51 | $23,409 | $7,409 | 31.6% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 17 | 17 | $2,635 | $979.80 | 37.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 152 | 380 | $60,892 | $21,793 | 35.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 133 | 198 | $45,440 | $16,191 | 35.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 65 | 65 | $28,431 | $10,559 | 37.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 104 | 106 | $25,072 | $8,867 | 35.4% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 11 | 11 | $4,501 | $1,625 | 36.1% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 13 | 13 | $2,015 | $694.02 | 34.4% |
About Dr. David Henderson, MD
Dr. David Henderson, MD is a Internal Medicine healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821065095.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Henderson, MD has received a total of $9,893 in payments from pharmaceutical and medical device companies, with $1,963 received in 2024. These payments were reported across 525 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($9,780).
As a Medicare-enrolled provider, Henderson has provided services to 1,677 Medicare beneficiaries, totaling 3,030 services with total Medicare billing of $225,480. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist
- Location Charlotte, NC
- Active Since 03/07/2006
- Last Updated 06/14/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1821065095
Products in Payments
- XARELTO (Drug) $1,160
- ENTRESTO (Drug) $956.93
- ELIQUIS (Drug) $802.32
- JARDIANCE (Drug) $698.96
- XIFAXAN (Drug) $666.54
- LifeVest (Device) $391.06
- GIVLAARI (Drug) $337.04
- NUZYRA (Drug) $309.00
- TEFLARO (Drug) $269.80
- DIFICID (Drug) $201.46
- WATCHMAN (Device) $186.50
- SMARTVEST (Device) $138.24
- BRILINTA (Drug) $133.21
- DALVANCE (Drug) $130.88
- VYNDAQEL (Drug) $130.87
- STIOLTO RESPIMAT (Drug) $124.99
- LOKELMA (Drug) $116.97
- FARXIGA (Drug) $108.97
- (8876) Vest Therapy Und (Device) $106.83
- Ozempic (Drug) $94.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Charlotte
Ryan Jacobs, Md, MD
Internal Medicine — Payments: $1.7M
Internal Medicine $1.7M
Saad Usmani, Md, MD
Internal Medicine — Payments: $747,509
Internal Medicine $747,509
Michael Rinaldi, Md, MD
Internal Medicine — Payments: $646,787
Internal Medicine $646,787
Dr. Richard Browne, M.d, M.D
Internal Medicine — Payments: $638,169
Internal Medicine $638,169
Sanjeev Gulati, Md, MD
Internal Medicine — Payments: $598,822
Internal Medicine $598,822
Dr. Raymond Thertulien, M.d, M.D
Internal Medicine — Payments: $584,601
Internal Medicine $584,601